Glycan engagement by viruses: Receptor switches and specificity

Annual Review of Virology

Volumn 1, Issue 1, 2014, Pages 285-306

  Ströh, Luisa J ^a   Stehle, Thilo ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronavirus; Polyomavirus; Reovirus; Rotavirus; Sialic acid; Sulfated glycosaminoglycan

Indexed keywords

BLOOD GROUP ANTIGEN; CARBOHYDRATE; GLYCAN; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN RECEPTOR; SIALIC ACID; SIALIC ACID RECEPTOR; UNCLASSIFIED DRUG; VIRAL GLYCAN RECEPTOR; VIRUS RECEPTOR;

ARTICLE; BINDING SITE; CORONAVIRIDAE; CRYSTAL STRUCTURE; HOST RANGE; NONHUMAN; PATHOGENICITY; POLYOMAVIRUS; PRIORITY JOURNAL; PROTEIN INTERACTION; REOVIRIDAE; VIRUS; VIRUS ATTACHMENT;

CORONAVIRUS; ORTHOREOVIRUS; POLYOMAVIRUS; ROTAVIRUS;

EID: 85016948726     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-031413-085417     Document Type: Article

References (166)

1. HirstGK. 1941. The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94:22-23
2. Fazekas de St Groth S. 1948. Viropexis, the mechanism of influenza virus infection. Nature 162:294-95
3. Hirst GK. 1948. The nature of the virus receptors of red cells. I. Evidence on the chemical nature of the virus receptors of red cells and of the existence of a closely analogous substance in normal serum. J. Exp. Med. 87:301-14
4. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. 1988. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333:426-31
5. Nilsson EC, Storm RJ, Bauer J, Johansson SMC, Lookene A, et al. 2011. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 17:105-9
6. Song X, Yu H, Chen X, Lasanajak Y, Tappert MM, et al. 2011. A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses. J. Biol. Chem. 286:31610-22
7. Heimburg-Molinaro J, Tappert M, Song X, Lasanajak Y, Air G, et al. 2012. Probing virus-glycan interactions using glycan microarrays. Methods Mol. Biol. 808:251-67
8. Padler-Karavani V, Song X, YuH,Hurtado-ZiolaN,Huang S, et al. 2012. Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays. J. Biol. Chem. 287:22593-608
9. Palma AS, Feizi T, Childs RA, Chai W, Liu L. 2014. The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome. Curr. Opin. Chem. Biol. 18:87-94
10. Mayer M, Meyer B. 1999. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew. Chem. Int. Ed. 38:1784-88
11. Haselhorst T, BlanchardH, Frank M, Kraschnefski MJ, KiefelMJ, et al. 2007. STDNMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8∗core. Glycobiology 17:68-81
12. Rademacher C, Krishna NR, Palcic M, Parra F, Peters T. 2008. NMR experiments reveal the molecular basis of receptor recognition by a calicivirus. J. Am. Chem. Soc. 130:3669-75
13. FiegeB,Rademacher C, Cartmell J, KitovPI, Parra F, Peters T. 2012. Molecular details of the recognition of blood group antigens by a human norovirus as determined by STDNMRspectroscopy. Angew. Chem. Int. Ed. 51:928-32
14. Neu U, Allen SA, Blaum BS, Liu Y, Frank M, et al. 2013. A structure-guided mutation in the major capsid protein retargets BK polyomavirus. PLoS Pathog. 9:e1003688
15. Varki NM, Varki A. 2007. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab. Investig. 87:851-57
16. Varki A, Schauer R. 2009. Sialic acids. In Essentials of Glycobiology, ed. A Varki, RD Cummings, JD Esko, HH Freeze, P Stanley, et al., pp. 199-217. Cold Spring Harbor, NY: Cold Spring Harb. Lab. Press
17. Varki A, Gagneux P. 2012. Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253:16-36
18. Angata T, Varki A. 2002. Chemical diversity in the sialic acids and related α-keto acids: an evolutionary perspective. Chem. Rev. 102:439-69
19. Nie H, Li Y, Sun XL. 2012. Recent advances in sialic acid-focused glycomics. J. Proteomics 75:3098-112
20. Neu U, Bauer J, Stehle T. 2011. Viruses and sialic acids: rules of engagement. Curr. Opin. Struct. Biol. 21:610-18
21. Brisson JR, BaumannH, Imberty A, Perez S, JenningsHJ. 1992. Helical epitope of the group Bmeningococcal α(2-8)-linked sialic acid polysaccharide. Biochemistry 31:4996-5004
22. Nakata D, Troy FA II. 2005. Degree of polymerization (DP) of polysialic acid (polySia) on neural cell adhesion molecules (N-CAMS): development and application of a new strategy to accurately determine the DP of polySia chains on N-CAMS. J. Biol. Chem. 280:38305-16
23. Sato C, Kitajima K. 2013. Disialic, oligosialic and polysialic acids: distribution, functions and related disease. J. Biochem. 154:115-36
24. Yu RK,Tsai YT, ArigaT, YanagisawaM. 2011. Structures, biosynthesis, and functions of gangliosides-an overview. J. Oleo Sci. 60:537-44
25. Finne J. 1982. Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. J. Biol. Chem. 257:11966-70
26. Roth J, Zuber C, Wagner P, Taatjes DJ, Weisgerber C, et al. 1988. Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc. Natl. Acad. Sci. USA 85:2999-3003
27. Hildebrandt H, Becker C, Gluer S, Rosner H, Gerardy-Schahn R, Rahmann H. 1998. Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth. Cancer Res. 58:779-84
28. Janas T, Janas T. 2011. Membrane oligo-and polysialic acids. Biochim. Biophys. Acta 1808:2923-32
29. Viswanathan K, Chandrasekaran A, Srinivasan A, Raman R, Sasisekharan V, Sasisekharan R. 2010. Glycans as receptors for influenza pathogenesis. Glycoconj. J. 27:561-70
30. Ge SQ,Wang ZL. 2011. An overview of influenza A virus receptors. Crit. Rev. Microbiol. 37:157-65
31. Imai M, Kawaoka Y. 2012. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr. Opin. Virol. 2:160-67
32. Wilks S, deGraaf M, Smith DJ, BurkeDF. 2012. A review of influenza haemagglutinin receptor binding as it relates to pandemic properties. Vaccine 30:4369-76
33. Matrosovich M, Herrler G, Klenk HD. 2013. Sialic acid receptors of viruses. Top. Curr. Chem. doi: 10.1007/128-2013-466
34. Dalianis T, Hirsch HH. 2013. Human polyomaviruses in disease and cancer. Virology 437:63-72
35. DeCaprio JA, Garcea RL. 2013. A cornucopia of human polyomaviruses. Nat. Rev. Microbiol. 11:264-76
36. Stehle T, Yan Y, Benjamin TL, Harrison SC. 1994. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369:160-63
37. Stehle T, Harrison SC. 1996. Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 4:183-94
38. Stehle T, Harrison SC. 1997. High-resolution structure of a polyomavirusVP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 16:5139-48
39. Neu U, Woellner K, Gauglitz G, Stehle T. 2008. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc. Natl. Acad. Sci. USA 105:5219-24
40. Neu U, Maginnis MS, Palma AS, Ströh LJ, Nelson CD, et al. 2010. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8:309-19
41. Neu U, Hengel H, Blaum BS, Schowalter RM, Macejak D, et al. 2012. Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog. 8:e1002738
42. Neu U, Khan ZM, Schuch B, Palma AS, Liu Y, et al. 2013. Structures of B-lymphotropic polyomavirus VP1 in complex with oligosaccharide ligands. PLoS Pathog. 9:e1003714
43. Khan ZM, Liu Y, Neu U, Gilbert M, Ehlers B, et al. 2014. Crystallographic and glycan microarray analysis of human polyomavirus 9 VP1 identifies N-glycolyl neuraminic acid as a receptor candidate. J. Virol. 88:6100-11
44. van der Meijden E, Janssens RWA, LauberC, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC. 2010. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog. 6:e1001024
45. Liu CK, Wei G, Atwood WJ. 1998. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal α(2-6)-linked sialic acids. J. Virol. 72:4643-49
46. Komagome R, Sawa H, Suzuki T, Suzuki Y, Tanaka S, et al. 2002. Oligosaccharides as receptors for JC virus. J. Virol. 76:12992-3000
47. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA. 2003. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22:4346-55
48. Low JA, Magnuson B, Tsai B, Imperiale MJ. 2006. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 80:1361-66
49. Campanero-Rhodes MA, Smith A, Chai WG, Sonnino S, Mauri L, et al. 2007. N-Glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 81:12846-58
50. Varki A. 2009. Multiple changes in sialic acid biology during human evolution. Glycoconj. J. 26:231-45
51. PhoMT, Ashok A, Atwood WJ. 2000. JC virus enters human glial cells by clathrin-dependent receptormediated endocytosis. J. Virol. 74:2288-92
52. Eash S, Querbes W, Atwood WJ. 2004. Infection of Vero cells by BK virus is dependent on caveolae. J. Virol. 78:11583-90
53. Zheng HY, Takasaka T, Noda K, Kanazawa A, Mori H, et al. 2005. New sequence polymorphisms in the outer loops of the JC polyomavirus major capsid protein (VP1) possibly associated with progressive multifocal leukoencephalopathy. J. Gen. Virol. 86:2035-45
54. Sunyaev SR, Lugovskoy A, Simon K, Gorelik L. 2009. Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLoS Genet. 5:e1000368
55. Delbue S, Branchetti E, Bertolacci S, Tavazzi E, Marchioni E, et al. 2009. JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy. J. Neurovirol. 15:51-56
56. Gorelik L, Reid C, Testa M, Brickelmaier M, Bossolasco S, et al. 2011. Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J. Infect. Dis. 204:103-14
57. Magaldi TG, Buch MH, Murata H, Erickson KD, Neu U, et al. 2012. Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism. J. Virol. 86:7028-42
58. Maginnis MS, Ströh LJ, Gee GV, O'Hara BA, Derdowski A, et al. 2013. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding. mBio 4:e00247-13
59. Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Cuburu N, Buck CB. 2013. BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism. J. Virol. 87:10105-13
60. Rolsma MD, Kuhlenschmidt TB, Gelberg HB, Kuhlenschmidt MS. 1998. Structure and function of a ganglioside receptor for porcine rotavirus. J. Virol. 72:9079-91
61. Lofling J, Lyi SM, Parrish CR, Varki A. 2013. Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid. Virology 440:89-96
62. Yu X, Dang VT, Fleming FE, von Itzstein M, Coulson BS, Blanchard H. 2012. Structural basis of rotavirus strain preference towardN-acetyl-orN-glycolylneuraminic acid-containing receptors. J. Virol. 86:13456-66
63. LangereisMA, Zeng QH,Heesters B, Huizinga EG, de Groot RJ. 2012. Themurine coronavirus hemagglutinin-esterase receptor-binding site: a major shift in ligand specificity through modest changes in architecture. PLoS Pathogens 8:e1002492
64. Bardor M, Nguyen DH, Diaz S, Varki A. 2005. Mechanism of uptake and incorporation of the nonhuman sialic acid N-glycolylneuraminic acid into human cells. J. Biol. Chem. 280:4228-37
65. Inoue S, Sato C, Kitajima K. 2010. Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells. Glycobiology 20:752-62
66. Yu X, Coulson BS, Fleming FE, Dyason JC, von Itzstein M, BlanchardH. 2011. Novel structural insights into rotavirus recognition of ganglioside glycan receptors. J. Mol. Biol. 413:929-39
67. Zeng QH, Langereis MA, van Vliet ALW, Huizinga EG, de Groot RJ. 2008. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc. Natl. Acad. Sci. USA 105:9065-69
68. Mandal C, Schwartz-Albiez R, Vlasak R. 2012. Functions and biosynthesis of O-acetylated sialic acids. Top. Curr. Chem. doi: 10.1007/128-2011-310
69. de Groot RJ. 2006. Structure, function and evolution of the hemagglutinin-esterase proteins of coronaand toroviruses. Glycoconj. J. 23:59-72
70. Langereis MA, Zeng Q, Gerwig GJ, Frey B, von Itzstein M, et al. 2009. Structural basis for ligand and substrate recognition by torovirus hemagglutinin esterases. Proc. Natl. Acad. Sci. USA 106:15897-902
71. Kunkel F, Herrler G. 1993. Structural and functional analysis of the surface protein of human coronavirus OC43. Virology 195:195-202
72. Peng G, Xu L, Lin YL, Chen L, Pasquarella JR, et al. 2012. Crystal structure of bovine coronavirus spike protein lectin domain. J. Biol. Chem. 287:41931-38
73. Langereis MA, van Vliet ALW, Boot W, de Groot RJ. 2010. Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated by hemagglutinin-esterase and not by the spike protein. J. Virol. 84:8970-74
74. Peng G, SunD,Rajashankar KR,Qian Z, Holmes KV,Li F. 2011. Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. Proc. Natl. Acad. Sci. USA 108:10696-701
75. Lang J, Yang N, Deng J, Liu K, Yang P, et al. 2011. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS ONE 6:e23710
76. Reiter DM, Frierson JM, Halvorson EE, Kobayashi T, Dermody TS, Stehle T. 2011. Crystal structure of reovirus attachment protein σ1 in complex with sialylated oligosaccharides. PLoS Pathog. 7:e1002166
77. Reiss K, Stencel JE, Liu Y, Blaum BS, Reiter DM, et al. 2012. The GM2 glycan serves as a functional coreceptor for serotype 1 reovirus. PLoS Pathog. 8:e1003078
78. Weiner HL, PowersML, Fields BN. 1980. Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J. Infect. Dis. 141:609-16
79. Tyler KL, McPhee DA, Fields BN. 1986. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 233:770-74
80. Lee PW, Hayes EC, Joklik WK. 1981. Protein σ1 is the reovirus cell attachment protein. Virology 108:156-63
81. Nibert ML, Dermody TS, Fields BN. 1990. Structure of the reovirus cell-attachment protein: a model for the domain organization of σ1. J. Virol. 64:2976-89
82. Duncan R, Horne D, Cashdollar LW, Joklik WK, Lee PW. 1990. Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus. Virology 174:399-409
83. Chappell JD, Prota AE, Dermody TS, Stehle T. 2002. Crystal structure of reovirus attachment protein σ1 reveals evolutionary relationship to adenovirus fiber. EMBO J. 21:1-11
84. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, et al. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-51
85. Ravn V, Dabelsteen E. 2000. Tissue distribution of histo-blood group antigens. APMIS 108:1-28
86. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoën N, et al. 2001. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83:565-73
87. Tan M, Jiang X. 2010. Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog. 6:e1000983
88. Ruvoën-Clouet N, Belliot G, Le Pendu J. 2013. Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. Rev. Med. Virol. 23:355-66
89. Yeager M, Dryden KA, Olson NH, Greenberg HB, Baker TS. 1990. Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J. Cell Biol. 110:2133-44
90. Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, et al. 2011. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 156:1397-413
91. Fiore L, Greenberg HB, Mackow ER. 1991. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181:553-63
92. DowlingW, Denisova E, LaMonica R, Mackow ER. 2000. Selective membrane permeabilization by the rotavirusVP5∗ protein is abrogated bymutations in an internal hydrophobic domain. J. Virol. 74:6368-76
93. Dormitzer PR, Greenberg HB, Harrison SC. 2001. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5∗ core. J. Virol. 75:7339-50
94. Monnier N, Higo-Moriguchi K, SunZY, Prasad BV,Taniguchi K, DormitzerPR. 2006. High-resolution molecular and antigen structure of the VP8∗ core of a sialic acid-independent human rotavirus strain. J. Virol. 80:1513-23
95. BlanchardH, Yu X, Coulson BS, von ItzsteinM. 2007. Insight into host cell carbohydrate recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8∗). J. Mol. Biol. 367:1215-26
96. Kraschnefski MJ, Bugarcic A, Fleming FE, Yu X, von Itzstein M, et al. 2009. Effects on sialic acid recognition of amino acid mutations in the carbohydrate-binding cleft of the rotavirus spike protein. Glycobiology 19:194-200
97. Haselhorst T, Fiebig T, Dyason JC, Fleming FE, Blanchard H, et al. 2011. Recognition of the GM3 ganglioside glycan by rhesus rotavirus particles. Angew. Chem. Int. Ed. 50:1055-58
98. Martinez MA, Lopez S, Arias CF, Isa P. 2013. Gangliosides have a functional role during rotavirus cell entry. J. Virol. 87:1115-22
99. Dormitzer PR, Sun ZYJ, Wagner G, Harrison SC. 2002. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 21:885-97
100. Haselhorst T, Fleming FE, Dyason JC,HartnellRD, Yu X, et al. 2009. Sialic acid dependence in rotavirus host cell invasion. Nat. Chem. Biol. 5:91-93
101. Hu L, Crawford SE, Czako R, Cortes-Penfield NW, Smith DF, et al. 2012. Cell attachment protein VP8∗ of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485:256-59
102. Huang PW, Farkas T, Zhong WM, Thornton S, Morrow AL, Xi J. 2005. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79:6714-22
103. TanM, Xia M, Chen Y, Bu W, Hegde RS, et al. 2009. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS ONE 4:e5058
104. Chen Y, Tan M, Xia M, Hao N, Zhang XC, et al. 2011. Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog. 7:e1002152
105. Stuart AD, Brown TDK. 2007. α2,6-Linked sialic acid acts as a receptor for feline calicivirus. J. Gen. Virol. 88:177-86
106. Taube S, Perry JW, Yetming K, Patel SP, Auble H, et al. 2009. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J. Virol. 83:4092-101
107. Taube S, Perry JW,McGreevy E, Yetming K, Perkins C, et al. 2012. Murine noroviruses bind glycolipid and glycoprotein attachment receptors in a strain-dependent manner. J. Virol. 86:5584-93
108. Esko JD, Kimata K, Lindahl U. 2009. Proteoglycans and sulfated glycosaminoglycans. In Essentials of Glycobiology, ed. A Varki, RDCummings, JD Esko,HHFreeze, P Stanley, et al., pp. 229-48. Cold Spring Harbor, NY: Cold Spring Harb. Lab. Press
109. Liu J, Thorp SC. 2002. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22:1-25
110. Olofsson S, Bergstrom T. 2005. Glycoconjugate glycans as viral receptors. Ann. Med. 37:154-72
111. Zhu WY, Li JJ, Liang GD. 2011. How does cellular heparan sulfate function in viral pathogenicity? Biomed. Environ. Sci. 24:81-87
112. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G. 2000. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268:382-90
113. Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, Lieber A. 2008. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog. 4:e1000189
114. Summerford C, Samulski RJ. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-45
115. Nahmias AJ, Kibrick S. 1964. Inhibitory effect of heparin on herpes simplex virus. J. Bacteriol. 87:1060-66
116. WuDunn D, Spear PG. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58
117. Shieh MT, WuDunn D, Montgomery RI, Esko JD, Spear PG. 1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1273-81
118. Neyts J, Snoeck R, Schols D, Balzarini J, Esko JD, et al. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189:48-58
119. Compton T, Nowlin DM, Cooper NR. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834-41
120. Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, et al. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278:41003-12
121. Schulze A, Gripon P, Urban S. 2007. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46:1759-68
122. Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. 2009. Heparan sulfate proteoglycans are required for cellular binding of the hepatitisEvirusORF2 capsid protein and for viral infection. J. Virol. 83:12714-24
123. Longarela OL, Schmidt TT, Schöneweis K, Romeo R, Wedemeyer H, et al. 2013. Proteoglycans act as cellular hepatitis delta virus attachment receptors. PLoS ONE 8:e58340
124. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, et al. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-71
125. DalrympleN,Mackow ER. 2011. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J. Virol. 85:9478-85
126. Roehrig JT, Butrapet S, Liss NM, Bennett SL, Luy BE, et al. 2013. Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion. Virology 441:114-25
127. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, et al. 1999. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 274:5810-22
128. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M. 2001. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75:1565-70
129. Dasgupta J, Bienkowska-Haba M, Ortega ME, Patel HD, Bodevin S, et al. 2011. Structural basis of oligosaccharide receptor recognition by human papillomavirus. J. Biol. Chem. 286:2617-24
130. Cruz L, Meyers C. 2013. Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS ONE 8:e68379
131. CerqueiraC,Liu Y, KuhlingL,ChaiW,HafeziW, et al. 2013. Heparin increases the infectivity of human papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol. 15:1818-36
132. Schowalter RM, Pastrana DV, Buck CB. 2011. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 7:e1002161
133. SaphireACS, BobardtMD, ZhangZ,David G, Gallay PA. 2001. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75:9187-200
134. Nasimuzzaman M, Persons DA. 2012. Cell membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol. Ther. 20:1158-66
135. Tamura M, Natori K, KobayashiM,MiyamuraT,TakedaN. 2004. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J. Virol. 78:3817-26
136. Hallak LK, Spillmann D, Collins PL, PeeplesME. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 74:10508-13
137. Dong J, Dong L, Mendez E, Tao Y. 2011. Crystal structure of the human astrovirus capsid spike. Proc. Natl. Acad. Sci. USA 108:12681-86
138. Byrnes AP,GriffinDE. 1998. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:7349-56
139. Gardner CL, Ebel GD, Ryman KD, Klimstra WB. 2011. Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence. Proc. Natl. Acad. Sci. USA 108:16026-31
140. Silva LA, Khomandiak S, Ashbrook AW,Weller R,Heise MT, et al. 2014. A single-amino-acid polymorphism in chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J. Virol. 88:2385-97
141. Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, et al. 1999. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 18:543-54
142. Fry EE, Newman JW, Curry S, Najjam S, Jackson T, et al. 2005. Structure of foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J. Gen. Virol. 86:1909-20
143. Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, et al. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-87
144. Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, Fuchs R, Blaas D. 2011. Entry of a heparan sulphate-binding HRV8 variant strictly depends on dynamin but not on clathrin, caveolin, and flotillin. Virology 412:55-67
145. Vlasak M, Goester I, Blaas D. 2005. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J. Virol. 79:5963-70
146. McLeish NJ, Williams CH, Kaloudas D, Roivainen MM, Stanway G. 2012. Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J. Virol. 86:11163-70
147. TanCW, PohCL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 87:611-20
148. O'Donnell J, Taylor KA, Chapman MS. 2009. Adeno-associated virus-2 and its primary cellular receptor-cryo-EM structure of a heparin complex. Virology 385:434-43
149. Levy HC, Bowman VD, Govindasamy L, McKenna R, Nash K, et al. 2009. Heparin binding induces conformational changes in adeno-associated virus serotype 2. J. Struct. Biol. 165:146-56
150. Xie Q, Spilman M, MeyerNL, Lerch TF, Stagg SM, ChapmanMS. 2013. Electron microscopy analysis of a disaccharide analog complex reveals receptor interactions of adeno-associated virus. J. Struct. Biol. 184:129-35
151. Asokan A, Schaffer DV, Samulski RJ. 2012. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 20:699-708
152. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. 2001. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75:6884-93
153. Walters RW, Yi SMP, Keshavjee S, Brown KE,Welsh MJ, et al. 2001. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276:20610-16
154. WuZ, Miller E, Agbandje-McKenna M, Samulski RJ. 2006.α2,3 andα2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80:9093-103
155. Agbandje-McKenna M, Kleinschmidt J. 2011. AAV capsid structure and cell interactions. Methods Mol. Biol. 807:47-92
156. Shen S, BryantKD, Brown SM, Randell SH, Asokan A. 2011. TerminalN-linked galactose is the primary receptor for adeno-associated virus 9. J. Biol. Chem. 286:13532-40
157. Xie Q, BuW, Bhatia S, Hare J, Somasundaram T, et al. 2002. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA 99:10405-10
158. Lerch TF, Xie Q, Chapman MS. 2010. The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion. Virology 403:26-36
159. Xie Q, Lerch TF, Meyer NL, Chapman MS. 2011. Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6). Virology 420:10-19
160. Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, et al. 2003. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 77:11072-81
161. Zhang F, Aguilera J, Beaudet JM, XieQ, Lerch TF, et al. 2013. Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus. Biochemistry 52:6275-85
162. Bell CL,Gurda BL, van VlietK, Agbandje-McKenna M, Wilson JM. 2012. Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid. J. Virol. 86:7326-33
163. DiMattia MA, Nam HJ, van Vliet K, Mitchell M, Bennett A, et al. 2012. Structural insight into the unique properties of adeno-associated virus serotype 9. J. Virol. 86:6947-58
164. Shen S, Horowitz ED, Troupes AN, Brown SM, Pulicherla N, et al. 2013. Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency. J. Biol. Chem. 288:28814-23
165. Mietzsch M, Broecker F, Reinhardt A, Seeberger PH, Heilbronn R. 2014. Differential AAV serotype-specific interaction patterns with synthetic heparins and other glycans. J. Virol. 88:2991-3003
166. Raff AB,Woodham AW, Raff LM, Skeate JG, Yan L, et al. 2013. The evolving field of human papillomavirus receptor research: a review of binding and entry. J. Virol. 87:6062-72